Mitochondrial targeting as a novel therapeutic approach to human disease: a translational program
MICHELAKIS, Evangelos D
7 enregistrements totalisant 8,048,210.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Instituts de recherche en santé du Canada | $8,048,210 | 7 enregistrements |
Enregistrements
Michelakis, Evangelos D
$3,862,604.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2016-2017
Canada
MICHELAKIS, Evangelos D
$1,400,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2011-2012
Canada
CRC tier 1
MICHELAKIS, Evangelos D
$813,784.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2013-2014
Canada
A Functional Nuclear Pyruvate Dehydrogenase Complex is Important for a Mitochondria-Independent Generation of Acetyl-CoA and Histone Acetylation in the Nucleus
MICHELAKIS, Evangelos D
$813,550.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2013-2014
Canada
Mitochondrial suppression in pulmonary hypertension
MICHELAKIS, Evangelos D
$768,096.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2011-2012
Canada
Nogo, the ER-mitochondria unit and the vascular remodeling of pulmonary hypertension
MICHELAKIS, Evangelos D
$290,176.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2012-2013
Canada
Early phase clinical trials with the small molecule DCA in Pulmonary Arterial Hypertension
MICHELAKIS, Evangelos D
$100,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2012-2013
Canada
The Metabolic basis of Cancer Angiogenesis